Roche Holdings to acquire TIB Molbiol.

Roche Holdings, developer and manufacturer of pharmaceutical and diagnostic products, agreed to acquire TIB Molbiol, a German biotech group. Financial terms were not disclosed. “At the onset of the COVID-19 pandemic, our collaboration provided the first research-use-only SARS-CoV-2 detection test that was provided in January 2020, only days after the new coronavirus was first sequenced. Together, we can further improve patient outcomes with innovative diagnostic solutions that alleviate healthcare costs,” Thomas Schinecker, Roche Diagnostics CEO.